Oct 2026· ANPAbstract_CBN26· pp. S0291-S0291· 0 citations
TL;DR
Focal phenotypes represent uncommon initial presentations of myasthenia gravis and may delay diagnosis, and patients who initially presented with distal upper limb weakness maintained this pattern as the predominant clinical manifestation even after generalization.
Abstract
Background: Myasthenia gravis (MG) is an autoimmune disorder characterized by fluctuating muscle weakness. Although most patients present with ocular or generalized involvement, a subset exhibits focal and atypical phenotypes, which are less well recognized and may contribute to delayed diagnosis. Objective: To describe the clinical characteristics of a cohort of patients with atypical MG presentations followed at a referral centre for neuromuscular disorders. Methods: Patients with a confirmed diagnosis of MG were evaluated and classified as ocular, generalized, or atypical. Atypical cases were further categorized into head drop, isolated diaphragmatic paralysis, and selective muscle involvement. Patients were identified between 2000 and 2025. Data were retrospectively collected from medical records using a standardized proforma. The study was approved by the local ethics committee. Results: A total of 419 patients with MG were analysed, of whom 12 (2.9%) presented with a focal phenotype. Seven patients exhibited isolated diaphragmatic paralysis, one presented with dropped head syndrome, and four had distal upper limb weakness predominantly affecting arm extension and finger flexion. Regarding serological profile, seven patients were positive for acetylcholine receptor (AChR) antibodies—mainly associated with diaphragmatic and distal weakness phenotypes—while the patient with dropped head syndrome was MuSK-positive. Eight of the twelve patients had a Myasthenia Gravis Foundation of America (MGFA) classification >2A at presentation, indicating moderate to severe disease. During follow-up, 11 of 12 patients progressed to generalized MG, except for the patient with dropped head syndrome. Notably, patients who initially presented with distal upper limb weakness maintained this pattern as the predominant clinical manifestation even after generalization. At the last clinical evaluation, 10 of the 12 patients had MGFA ≤2A. Conclusion: Focal phenotypes represent uncommon initial presentations of myasthenia gravis and may delay diagnosis. Although most patients progressed to generalized disease, specific patterns such as distal upper limb weakness may persist throughout the disease course.
The absence of subsequent myasthenic crises after appropriate management suggests that concomitant use of pyridostigmine and azathioprine - both available in SUS - may represent an effective approach to reduce symptoms and improve patients’ quality of life.
Gabriel Rodrigues, Luciana Borges Ferreira, Camilly Vitória Cansan Loss et al.· ANPAbstract_CBN26· 0 citations
Background: Myasthenia gravis (MG) is an autoimmune disorder characterized by fluctuating skeletal muscle weakness and fatigability due to impaired neuromuscular transmission. Its clinical expression is heterogeneous. The epidemiology, age at onset, patterns of clinical involvement, and disease trajectory vary across p...
Amanda Vitória Freire de Oliveira, Lucas Grobério Moulim, Manoella Guerra de Albuquerque Bueno et al.· ANPAbstract_CBN26· 0 citations
Background: Myasthenia gravis (MG) is an autoimmune disorder characterized by the production of autoantibodies that impair neuromuscular transmission, leading to fluctuating muscle weakness. Although diagnosis and treatment have evolved over recent decades, clinical presentation, laboratory findings, and therapeutic ma...
Julia Fernandes Alves de Oliveira, Maria Clara Magalhães Imbico, L. M. de Matos et al.· ANPAbstract_CBN26· 0 citations
Background: Myasthenia Gravis (MG) is an autoimmune disease marked by postsynaptic dysfunction at the neuromuscular junction. It usually shows a bimodal age distribution, with early- and late onset peaks. More recently, some authors have proposed a very late onset subgroup (≥65 years)- VLOMG, though its clinical releva...
N. M. Athayde, Guilherme Augusto de Oliveira Soares, Lara Albuquerque Brito et al.· ANPAbstract_CBN26· 0 citations
Background: Congenital Myasthenic Syndromes (CMS) comprise a heterogeneous group of neuromuscular junction disorders of genetic etiology, with over 35 causative genes identified to date. The majority of cases exhibit an autosomal recessive inheritance pattern, although autosomal dominant mutations have been reported in...
João Paulo Borges de Melo, Maria Izabel Rodrigues, P. C. de Oliveira et al.· ANPAbstract_CBN26· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.